The highlights of ERS 2019 by Jan De Backer, CEO of Fluidda
October 24, 2019 4:21 pm Leave your thoughtsAt ERS 2019, Jan de Backer, CEO of Fluidda, explains why during the past years, the treatment of lung diseases is shifting from using more common bronchodilatators to more personalized... View Article